Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

URGNURGN
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in UROGEN PHARMA LTD

GOLDMAN SACHS GROUP INC holds 819,834 shares of URGN (UROGEN PHARMA LTD), worth $30.2M as of 2026-Q2. The position was increased (+37.0% shares). URGN represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$30.2M

Current Shares

819,834

Total Value Change

+$26.8M

Total Shares Change

+502,312

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
819,834
+37.0%
$30.2M0.0%$36.80
38
2026-Q1
Increased
598,528
+30.2%
$10.8M0.0%$18.82
35
2025-Q4
Increased
459,722
+8.2%
$10.8M0.0%$23.17
30
2025-Q3
Increased
424,916
+46.2%
$8.5M0.0%$19.14
37
2025-Q2
Increased
290,577
+2.2%
$4M0.0%$13.49
27
2025-Q1
Decreased
284,334
-10.4%
$3.1M0.0%$11.20
0
2024-Q4
New
317,522
-
$3.4M0.0%$10.52
37

Other major holders of URGN: RTW INVESTMENTS, LP, BlackRock, Inc., MENORA MIVTACHIM HOLDINGS LTD.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used